Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
06/08/2011 | CN102088961A Eprosartan compositions |
06/08/2011 | CN102085372A Application of Notch pathway inhibitor in treatment of tumors caused by activation of mTOR |
06/08/2011 | CN102085358A Application of medicament containing hirudin, hementerin and hyaluronidase |
06/08/2011 | CN102085349A Preparation method and application of compound barbary wolfberry fruit preparation |
06/08/2011 | CN102085322A Detection method of traditional Chinese medicine composition for treating hematuria |
06/08/2011 | CN102085299A Chinese patent medicine for treating prostatitis and preparation method thereof |
06/08/2011 | CN102085277A Medicament for treating benign prostatic hyperplasia and preparation method thereof |
06/08/2011 | CN102085273A Extracting method of extractive for tonifying kidney and nourishing blood and medical composition thereof |
06/08/2011 | CN102085253A Compound green vitriol capsule |
06/08/2011 | CN102085232A Astragalus dispersible tablets |
06/08/2011 | CN101816754B Orally-administered Chinese medicinal composition for treating acute gestational urinary infection |
06/08/2011 | CN101658586B Medicament for treating male venereal disease and preparation method thereof |
06/08/2011 | CN101596303B Pharmaceutical compound for curing prostatitis and prostate hyperplasia and preparation method and preparation thereof |
06/08/2011 | CN101433653B Chinese medicinal composition for treating prostatitis and prostatoplasia |
06/08/2011 | CN101406556B Chinese medicine preparation for treating acute prostatitis, prostatic hyperplasia and preparation method thereof |
06/08/2011 | CN101317941B Medicament for promoting diuresis and easing pain |
06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
06/07/2011 | US7956187 Method for decreasing opioid metabolism |
06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
06/07/2011 | CA2647932C Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
06/07/2011 | CA2628607C Androgen synthesis inhibitors |
06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
06/07/2011 | CA2490573C Improved transdermal delivery system |
06/07/2011 | CA2435685C Desaturase genes and uses thereof |
06/07/2011 | CA2418422C Novel kallikrein gene |
06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
06/03/2011 | WO2011066006A2 Methods for treating aids |
06/03/2011 | WO2011065519A1 Substituted oxopiperazine compound |
06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
06/02/2011 | US20110130454 Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
06/02/2011 | US20110130436 Caspase inhibitors and uses thereof |
06/02/2011 | US20110130424 Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties |
06/02/2011 | US20110130421 Methods and Compositions for the Treatment of Chronic Renal Hypertension |
06/02/2011 | US20110130420 Isoquinolinone derivatives as nk3 antagonists |
06/02/2011 | US20110130414 Novel fused thiazolo and oxazolo pyrimidinones |
06/02/2011 | US20110130407 Isoquinolinone derivatives as nk3 antagonists |
06/02/2011 | US20110130400 Trpv4 antagonists |
06/02/2011 | US20110130376 New no releasing steroids derivatives |
06/02/2011 | US20110130331 Modified growth hormones |
06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
06/01/2011 | EP2327418A1 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from other viruses |
06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
06/01/2011 | EP2326668A1 Anti-il-12/il-23 antibodies |
06/01/2011 | EP2326645A1 Compound with serotoninergic activity, process for preparing it and pharmaceutical composition comprising it |
06/01/2011 | EP2326644A1 Urotensin ii receptor antagonists |
06/01/2011 | EP1584925B1 Novel screening method |
06/01/2011 | EP1386608B1 Remedial agent for glomerular disease |
06/01/2011 | CN102083810A Activator for peroxisome proliferator-activated receptor |
06/01/2011 | CN102083787A Vinyl substituted fatty acids |
06/01/2011 | CN102083437A Treatment of herpes virus related diseases |
06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
06/01/2011 | CN102079763A Dioxabicyclo-octane compound, preparation method and application thereof |
06/01/2011 | CN102079750A Cefuroxime sodium compound and new preparation method thereof |
06/01/2011 | CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
06/01/2011 | CN102079743A Dipeptidyl peptidase inhibitors |
06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
06/01/2011 | CN102078585A Traditional Chinese medicine for treating kidney deficiency |
06/01/2011 | CN102078578A Traditional Chinese medicine composition for treating enuresis due to spleen-lung vital energy deficiency |
06/01/2011 | CN102078559A Chinese medicinal composition with functions of tonifying kidney and strengthening brain |
06/01/2011 | CN102078557A Medicament for treating enuresis |
06/01/2011 | CN102078553A Chinese medicine composition for treating liver meridian damp heat enuresis |
06/01/2011 | CN102078552A Traditional Chinese medicine composition for treating enuresis due to kidney-qi asthenia cold |
06/01/2011 | CN102078527A Traditional Chinese medicine formula for treating urinary calculus |
06/01/2011 | CN102078505A Chinese herbal medicine for treating prostatitis |
06/01/2011 | CN102078489A Traditional Chinese medicine preparation for non-gonococcal urethritis |
06/01/2011 | CN102078485A Preparation method and application of compound dogwood preparation |
06/01/2011 | CN102078483A Chinese patent medicine (Bezoar Qianliekang Turunda) for treating prostate disease and preparation method thereof |
06/01/2011 | CN102078480A Nano element traditional Chinese medicine negative ion far infrared electromagnetic wave-resistant life prolonging medicinal liquor |
06/01/2011 | CN102078476A Traditional Chinese medicine composition for treatment of chronic nephritis |
06/01/2011 | CN102078440A Traditional Chinese medicine composition for kidney calculi |
06/01/2011 | CN102078401A Traditional Chinese medicinal composition for treating chronic primary glomerulus diseases and application thereof |
06/01/2011 | CN102078394A Aconite extract-containing medicinal composition, preparation method and application thereof |
06/01/2011 | CN102078388A Traditional Chinese medicine composition for treating renal colic with upper urinary calculi |
06/01/2011 | CN102078382A Traditional Chinese medicine decoction for treating difficult urination |
06/01/2011 | CN101653569B Medicine for curing bladder neoplasm |
06/01/2011 | CN101618051B Novel medicinal use of active parts of abelmoschus manihot general flavones |
06/01/2011 | CN101468097B Chinese medicinal composition for nourishing liver and kidney, moistening intestines and relaxing piss, preparation and method for preparing the same |
06/01/2011 | CN101416957B Use of resveratrol or naringenin in preventing and treating diabetic nephropathy |
06/01/2011 | CN101361732B Medicinal preparation containing garcinia acid and use thereof |
06/01/2011 | CN101341960B Concentrated tomato processing technique |
06/01/2011 | CN101194991B Qi replenishing and spleen enlivening Chinese medicine |
06/01/2011 | CN101099860B Use of erythropoietin |
05/31/2011 | US7951972 Human adam-10 inhibitors |
05/31/2011 | CA2533515C Heteroaryl-tetrahydropyridyl compounds useful for treating or preventing pain |
05/31/2011 | CA2483241C Novel diazabicyclononene derivatives |
05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
05/31/2011 | CA2231772C Advanced glycation end-product intermediaries and post-amadori inhibition |
05/26/2011 | WO2011062550A1 Benzoimidazole compounds and uses thereof |
05/26/2011 | WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same |
05/26/2011 | WO2011062194A1 Aminopyridine derivative |
05/26/2011 | WO2011061330A2 Use of physiological cooling active ingredients, and agents containing such active ingredients |
05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
05/26/2011 | US20110124695 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors |
05/26/2011 | US20110124680 Novel anthranilamide pyridinureas as vascular endothelial growth factor (vegf) receptor kinase inhibitors |
05/26/2011 | US20110124671 Spiroindenes and spiroindanes as modulators of chemokine receptors |
05/26/2011 | US20110124658 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
05/26/2011 | US20110124642 Potassium channel modulators |